ReviewJournal of personalized medicine2024

Efficacy and Safety of Anti-CD38 Monoclonal Antibodies in Patients with Relapsed or Refractory Multiple Myeloma: A Meta-Analysis of Randomized Clinical Trials.

Francisco Cezar Aquino de Moraes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.